How to map disease-specific changes using innovative LC-MS/MS-based omics approaches

June 26, 2025 – 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT

Mass spectrometry coupled with liquid chromatography (LC-MS/MS) has become a cornerstone of clinical research for the analysis of biomarkers indicative of disease. The integration of this technology across omics applications provides significant advantages in terms of assay sensitivity, specificity, robustness, and multiplexing. These benefits are enabling researchers to gain new insights into disease etiology and pathogenesis through the identification and quantitation of disease-specific biomarkers.

In this webinar, Professor Martin Giera, Leiden University Medical Center and Professor Antonin Lamazière, Sorbonne University and Saint Antoine’s Hospital, will demonstrate how the latest advancements in mass spectrometry-based omics are providing a comprehensive assessment of disease mechanisms and patient-specific treatment responses.

The presentations will showcase several examples of how the integration of LC-MS/MS technology across various omics applications provides disease state evaluation and monitoring, ultimately resulting in more personalized and effective patient care.

Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.

Webinar details

• Cost: Free to attend
• Location: Online
• Duration: 60 minutes

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.